News

Verizon Communications Inc. came up short on a key subscriber metric in the latest quarter, though it boosted several ...
His portfolio is still down from the April slump when everybody else’s accounts have gone up. This financial adviser works ...
Domino’s stock rallies as a big same-store sales beat and resumption of growth in deliveries offset an earnings miss.
iTeos Therapeutics has agreed to be acquired by privately held Concentra Biosciences in a deal initially worth roughly $385 million. iTeos on Monday said Concentra will pay nearly $10.05 a share in ...
Dynamix shares jumped in premarket trading Monday after it said it is merging with The Ether Reserve to create a new company known as The Ether Machine, with plans to manage over $1.5 billion in the ...
Rogers Communications upped the scale of its cash tender offers for several series of Canadian and U.S. bonds. The telecommunications and entertainment company said Monday it is raising the total ...
Roper Technologies raised its guidance for 2025 after notching higher profit and a jump in revenue for the second quarter.
Block Inc. shares jumped 9% in premarket following news late Friday that the parent company of Square [will join the S&P 500 this week]( ...
Verizon Communications shares rose 4.4% in premarket trading on Monday after it reported better-than-expected second-quarter results and raised guidance. Shares were trading around $42.65. The stock ...
Ryanair CEO Michael O'Leary is of the belief that the Aug. 1 deadline for a tariff deal between the U.S. and the European Union will get pushed back further. "What we suspect will happen is, I think, ...
Also on Friday, the Food and Drug Administration informally requested that Sarepta voluntarily pause shipments of another gene therapy, Elevidys, which is approved to treat a different type of ...
Protalix BioTherapeutics has hired Gilad Mamlok to succeed Eyal Rubin as the biopharmaceutical company's senior vice president and chief financial officer, effective Aug. 24.